The Foresight Institute’s Eric Drexler, who coined the word “nanotechnology” in the 1980s and is one of the field’s leading evangelists, has complained for years that the term has been watered down to the point of uselessness by researchers and companies who apply it to almost anything small. Now a legal complaint against Merrill Lynch, of all companies, may help to restore the definition to its original meaning – technologies that work on the scale of a nanometer, or a billionth of a meter, or less. The New York Times reports today that investment firm Asensio & Company has asked New York attorney general Eliot Spitzer to investigate Merrill Lynch “for including many companies that have little or nothing to do with nanotechnology” in the Merrill Lynch Nanotech Index, a list of 25 publicly traded companies introduced on April 1. Indeed, the index includes drug- and chemical-discovery companies such as Pharmacopeia and Symyx whose only claim to the “nanotechnology” label would seem to be that their products are made of atoms. A Merrill Lynch spokeswoman told the Times that the company is “in the process of performing a thorough and diligent inquiry” into the matter.
Download Merrill Lynch’s research report on its new nanotech index here.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Surgeons have successfully tested a pig’s kidney in a human patient
The test, in a brain-dead patient, was very short but represents a milestone in the long quest to use animal organs in human transplants.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.